Research progress of human intravenous immunoglobulin in the treatment ofCOVID-19 / 中国输血杂志
Chinese Journal of Blood Transfusion
;
(12): 547-556, 2021.
Article
Dans Chinois
| WPRIM
| ID: wpr-1004604
ABSTRACT
COVID-19 has brought huge damage and impact to the economy, society and healthy systems of China and the world. As a blood product prepared from healthy human blood, human intravenous immunoglobulin have played an active role in the fight against the epidemic. This article summarized the treatment plans, expert consensus and clinical reports in China concerning immunoglobulin in the treatment of COVID-19, and discussed the related possible mechanism of action, aiming at providing references for the drugs screening of COVID-19.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Journal of Blood Transfusion
Année:
2021
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS